Device Trial Radar · NCT06158750
To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
Last checked: Nov 20, 2026Latest source record: Jun 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
120
Planned (sponsor's estimate)
Start
Nov 17, 2023
Primary completion
Feb 28, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Shanghai Wallaby Medical Technologies Co.,Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Phenox GmbH; Beijing Wallaby Medical Technologies Co.,Inc.
- First posted
- Dec 6, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess safety and effectiveness of the p64/p48 MW HPC Flow Modulation Device.
Conditions
- Intracranial Aneurysm
Interventions
p64/p48 MW HPC Flow Modulation DeviceDevice
Endovascular intervention with p64/p48 MW HPC Flow Modulation Device was performed in patients diagnosed with intracranial aneurysms
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of complete occlusionTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xuanwu Hospital, Capital Medical University
Beijing, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.